← Eichor
Study identifier: NCT06558526 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients

Condition: Food Allergy  ·  Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

PhaseNA
Planned participants62
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Pectins are dietary fibers that have shown a health effect on patients with food allergy, as they are capable of modifying the composition of gastrointestinal microbiota, and producing an immunomodulatory effect. Preliminary results by the investigators show that the intervention for 2 months with pectins produces an increase in tolerance to peach, and changes in the microbiota compared to the group of patients treated with placebo. In this project, the investigators aim to study these clinical effects and the involved mechanisms. Moreover, the long-term effect (clinical reactivity to nsLTP and immunomodulatory effect) of the dietary intervention will be prospectively evaluated 6 months after the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Natalia Pérez Sánchez, MD, PhD  ·  +34 951290224  ·  nataliai.perez.sspa@juntadeandalucia.es

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Regional Universitario de MálagaMálaga, Málaga, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06558526